Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TNYA Tenaya Therapeutics, Inc. Common Stock
$0.39 0.26% +0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TNYA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Tenaya Therapeutics, Inc. Common Stock (TNYA)

Loading

Key Stats

Market cap. 87.2M
Enterprise value 13.1M
Trailing PE -0.66101692490659
Forward PE -0.99234694
PEG Ratio -0.01542372824782
Enterprise to EBITDA -0.173
Enterprise to revenue 9.805
Price to book MRQ 1.2548387
Price to sales TTM 65.33743

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 1.3M
EBITDA -75524000
Diluted EPS TTM -0.52
Total Cash (MRQ) 78.1M
Current ratio (MRQ) 4.522
Operating Cash Flow (TTM) -52325000

TNYA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TNYA News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.